Deep Dive into Great AI in iGaming: GR8 Tech’s AI Recommender
CSP
5 min read
8

Deep Dive into Great AI in iGaming: GR8 Tech’s AI Recommender

December 11, 2024
0

Reading Time: 3 minutes The buzz around artificial intelligence has reached a fever pitch, with industries scrambling to harness its potential. But amidst all the hype, the question remains: how is AI actually transforming the way we work, play, and interact? At iGaming News,

Continue Reading
CSP
4 min read
8

Hexagon Digital Wave partners with key players in the fire protection industry to accelerate the adoption of MAE technology – the most accurate method for testing SCBA cylinders

December 11, 2024
0

Reading Time: 3 minutes Centennial, CO, 10 December 2024:  Firefighters are dependent on safe air supplies to perform their job – Hexagon Digital Wave, a leading provider of innovative safety solutions, Denny’s Fire Control, a renowned supplier of fire protection equipment, and The Illinois Fire Service

Continue Reading
CSP
1 min read
8

#24-424 Listing of Derivatives at NGM

December 10, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
1 min read
15

#24-425 Delisting of Derivatives from NGM

December 10, 2024
0

Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
2 min read
11

eSportRanker Highlights the Crypto Revolution in Esports Betting

December 10, 2024
0

Reading Time: 2 minutes Stockholm, Sweden – December 2024 – eSportRanker, a leading ranking and review platform for esports enthusiasts, has unveiled groundbreaking insights into the growing integration of cryptocurrency in eSports Betting. According to the latest research, the market is projected to grow significantly, reaching

Continue Reading
CSP
2 min read
11

Medicover to evaluate a potential separate listing in india

December 10, 2024
0

Reading Time: < 1 minute The board of directors of Medicover AB (Publ) has today decided to evaluate the opportunity to list the Indian hospital subsidiary in India over the coming 12-24 months to further support its growth ambitions in the fast-growing Indian market. Medicover

Continue Reading
CSP
6 min read
27

Lundin Mining Publishes Swedish Short Form Document for Offer of New Lundin Mining Shares in Connection with the Acquisition of Filo Corp.

December 10, 2024
0

Reading Time: 4 minutes VANCOUVER, BC, December 10, 2024 /CNW/ – (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) is pleased to announce that Lundin Mining’s Swedish short-form document prepared in accordance with Article 1.4 da) and Annex IX of

Continue Reading
CSP
1 min read
28

Nordea Bank Abp: Repurchase of own shares on 10.12.2024

December 10, 2024
0

Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares10.12.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.12.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average

Continue Reading
CSP
6 min read
11

Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU

December 10, 2024
0

Reading Time: 4 minutes Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) did not meet the primary endpoint in the phase 3 study using 8 weeks of daily dosing followed by weekly maintenance dosing. The company’s focus going forward will be on the effective

Continue Reading
CSP
6 min read
15

Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU

December 10, 2024
0

Reading Time: 4 minutes Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) did not meet the primary endpoint in the phase 3 study using 8 weeks of daily dosing followed by weekly maintenance dosing. The company’s focus going forward will be on the effective

Continue Reading